Stay updated on RVT-1401 in ModeratetoSevere Graves' Ophthalmopathy Clinical Trial

Sign up to get notified when there's something new on the RVT-1401 in ModeratetoSevere Graves' Ophthalmopathy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the RVT-1401 in ModeratetoSevere Graves' Ophthalmopathy Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating that there has been an increase in the number of participants enrolled in the study evaluating RVT-1401 for the treatment of patients with Moderate to Severe Active Graves' Ophthalmopathy.
    Difference
    0.2%
    Check dated 2024-06-06T14:25:55.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for participation in the study, specifying age, clinical diagnosis, and other health conditions. Previously, no information was provided under the Participation Criteria section.
    Difference
    29%
    Check dated 2024-05-22T21:01:45.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:31:40.000Z thumbnail image

Stay in the know with updates to RVT-1401 in ModeratetoSevere Graves' Ophthalmopathy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the RVT-1401 in ModeratetoSevere Graves' Ophthalmopathy Clinical Trial page.